Medicines Containing The Active Ingredient Leuprorelin Atc L02Ae02

Deadline: 30 Nov 2026

Germany

Ref. No.: 11373594

EMD:Ref Document

Bid Value: Ref Document

217 Days Left

Medicines Containing The Active Ingredient Mesalazine Atc A07Ec02

Deadline: 30 Nov 2026

Germany

Ref. No.: 11362644

EMD:Ref Document

Bid Value: Ref Document

217 Days Left

Medicines Containing The Active Ingredient Pyridostigmine Atc N07Aa02

Deadline: 30 Nov 2026

Germany

Ref. No.: 11352492

EMD:Ref Document

Bid Value: Ref Document

217 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 11341666

EMD:Ref Document

Bid Value: Ref Document

248 Days Left

Medicines Containing The Active Ingredient Budesonide Atc A07Ea06

Deadline: 30 Nov 2026

Germany

Ref. No.: 11327805

EMD:Ref Document

Bid Value: Ref Document

217 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open House Model For The Active Ingredient Glatiramer Acetate Atc Code According To Who L03Ax13

Deadline: 31 May 2026

Germany

Ref. No.: 11324448

EMD:Ref Document

Bid Value: Ref Document

34 Days Left

Medicines Containing The Active Ingredient Filgrastim Atc L03Aa02

Deadline: 30 Nov 2026

Germany

Ref. No.: 11322015

EMD:Ref Document

Bid Value: Ref Document

217 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Guselkumab

Deadline: 10 Nov 2026

Germany

Ref. No.: 11310212

EMD:Ref Document

Bid Value: Ref Document

197 Days Left

Medicines Containing The Active Ingredient Epinephrine Atc C01Ca24

Deadline: 30 Nov 2026

Germany

Ref. No.: 11308823

EMD:Ref Document

Bid Value: Ref Document

217 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Guselkumab

Deadline: 10 Nov 2026

Germany

Ref. No.: 11305618

EMD:Ref Document

Bid Value: Ref Document

197 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code Sgb V By Means Of An Open House Model For The Active Ingredient Beclometasoneformoterolglycopyrronium Atc Code According To Who

Deadline: 31 Jan 2027

Germany

Ref. No.: 11225444

EMD:Ref Document

Bid Value: Ref Document

279 Days Left

Voluntary Transparency Professional Competence Management System

Deadline: 01 Jan 2027

Netherlands

Ref. No.: 11184101

EMD:Ref Document

Bid Value: Ref Document

249 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 11167484

EMD:Ref Document

Bid Value: Ref Document

248 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 11116448

EMD:Ref Document

Bid Value: Ref Document

248 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 11088648

EMD:Ref Document

Bid Value: Ref Document

248 Days Left

Discover Tenders by Pharmaceutical Articles Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Pharmaceutical Articles Sector

Filter Your Search

FREE Trial plan for all new users!